Industry Sessions
| 12:10 – 13:10 | INDUSTRY SUPPORTED SESSION Supported by Boehringer Ingelheim |
| 12:10 – 12:55 | MANAGING CARDIORENAL METABOLIC DISORDERS: A DECADE OF TRANSFORMATION WITH EMPA-REG AND THE PIVOTAL ROLE OF PRIMARY CARE
A DECADE OF CHANGE: THE PARADIGM-SHIFTING EMPA-REG OUTCOME TRIAL AND THE PATH FROM EVIDENCE TO ACTION MANAGING CHRONIC KIDNEY DISEASE: LONG-TERM PROTECTION STARTS EARLY THE POWER OF PREVENTION: THE PIVOTAL ROLE OF PRIMARY CARE PHYSICIANS IN MANAGING CARDIO-RENAL-METABOLIC DISORDERS |
| 12:55 – 13:10 | Panel Discussion |
|
|
|
| 16:10 – 17:10 | INDUSTRY PIPELINE SESSION: THE FUTURE OF MEDICATIONS |
| 16:10 – 16:30 | ASTRAZENECA VISION AND PIPELINE IN CARDIOVASCULAR, RENAL & METABOLISM. Robert Dewor, Astra Zeneca, Poland |
| 16:30 – 16:50 | TRANSFORMING CKM CARE: BREAKTHROUGHS WITH FINERENONE TREATMENT Per-Henrik Groop Finland |
| 16:50 – 17:10 | Panel Discussion |
| 11:10 – 12:10 | OBESITY: SIMPLE SOLUTIONS TO COMPLEX PROBLEMS supported by Novo Nordisk |
| 11:10 – 11:35 | HOW TO PROTECT PATIENTS FROM OBESITY-RELATED COMPLICATIONS Alina Kuryłowicz, Center of Postgraduate Medical Education, Poland |
| 11:35 – 12:00 | HOW TO EXTEND THE LIFE OF PATIENTS WITH OBESITY Paweł Balsam, Medical University of Warsaw, Poland |
| 12:00- 12:10 | Discussion and Q&A |
|
|
|
| 16:40 – 18:30 | INDUSTRY SYMPOSIUM supported by Boehringer Ingelheim |
| 16:40 – 17:00 | CARDIO-RENAL-METABOLIC CONNECTIONS: UNLOCKING LIVER HEALTH Leszek Czupryniak, Medical University of Warsaw, Poland |
| 17:00 – 18:30 | ADVANCING CAREMELO PATIENT CARE: MANAGING HF, CKD AND HTN Supported with an educational grant by Astra Zeneca |
| 17:00 – 17:20 | HEART FAILURE Mikhail Kosiborod, Astra Zeneca, USA |
| 17:20- 17:40 | CKD Ana Cebrián Cuenca, Murcian Health Service, Spain |
| 16:30 – 16:50 | HYPERTENSION Aleksander Prejbisz, National Institute of Cardiology in Warsaw, Poland |
| 18:00 – 18:30 | Panel Discussion |